Fuso Pharmaceutical Industries's quarterly market cap
increased
from Jun. 2025 (円18,103 Mil) to Sep. 2025 (円18,256 Mil) and
increased
from Sep. 2025 (円18,256 Mil) to Mar. 2026 (円20,173 Mil).
Fuso Pharmaceutical Industries's annual market cap
increased
from Mar. 2024 (円18,756 Mil) to Mar. 2025 (円20,855 Mil) but then
declined
from Mar. 2025 (円20,855 Mil) to Mar. 2026 (円20,173 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Fuso Pharmaceutical Industries's Enterprise Value for Today is 円41,697 Mil.
Fuso Pharmaceutical Industries (TSE:4538) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Fuso Pharmaceutical Industries Market Cap Related Terms
Fuso Pharmaceutical Industries Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fuso Pharmaceutical Industries's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fuso Pharmaceutical Industries Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fuso Pharmaceutical Industries's Market Cap distribution charts can be found below:
* The bar in red indicates where Fuso Pharmaceutical Industries's Market Cap falls into.
Fuso Pharmaceutical Industries Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fuso Pharmaceutical Industries (TSE:4538) has a Market Cap of 円18,235 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Fuso Pharmaceutical Industries and its competitors. According to the industry distribution chart, Fuso Pharmaceutical Industries ranks #600 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 58.6%.
Is Fuso Pharmaceutical Industries' Market Cap too high?
Fuso Pharmaceutical Industries' current Market Cap is 円18,235 Mil. Based on the distribution chart, Fuso Pharmaceutical Industries ranks #600 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fuso Pharmaceutical Industries ranks #600 out of 1024 companies for Market Cap. This places Fuso Pharmaceutical Industries in the lower half of its industry. The industry median Market Cap is 212.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.74, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Fuso Pharmaceutical Industries and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuso Pharmaceutical Industries's current Market Cap is 円18,235 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,544.23, compared to a current price of 円2,136.00 — trading 16% below its estimated fair value. The current Market Cap is 円18,235 Mil. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current Market Cap is 円18,235 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued.
The current stock price of 円2,136.00 is trading 16% below its estimated GF Value™ of 円2,544.23.
GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.
Key valuation signals for TSE:4538:
Market Cap: 円18,235 Mil
GF Value™: 円2,544.23 vs. price of 円2,136.00 (16% below fair value)
No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fuso Pharmaceutical Industries Business Description
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
51GF Score
Get the complete analysis for TSE:4538
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4538 has been successfully added to your 
